Abstract
Alzheimer’s disease is one of the most prevailing age-dependent neurodegenerative diseases and the most common cause of dementia. The pharmacological therapies available for the disease provide only symptomatic relief. Plants are being extensively investigated for Alzheimer’s as they are relatively safer and cheaper. This review summarizes recent findings suggesting anti- Alzheimer potential of the plants along with compounds or mechanisms responsible for their efficacy and their therapeutic targets. The findings of recent studies have revealed that the plants or the compounds isolated from them exhibit mitigative potential in Alzheimer’s disease by targeting amyloid beta, tau protein, cholinergic pathways via various enzymes like beta secretase, gamma secretase, acetylcholinesterase or receptors involved in these pathways. A number of putative compounds revealed from these studies can be investigated further for the mitigation of Alzheimer’s disease.
Keywords: Alzheimer's, amyloid beta, cholinergic pathways, neurodegenerative, tau protein, beta secretase.
Graphical Abstract
Current Traditional Medicine
Title:Potential Phytotherapeutic Approaches for the Treatment of Alzheimer’s Disease: An Overview
Volume: 7 Issue: 3
Author(s): Chetna Kaushik and Prarthna Yadav*
Affiliation:
- School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, Delhi, 110017,India
Keywords: Alzheimer's, amyloid beta, cholinergic pathways, neurodegenerative, tau protein, beta secretase.
Abstract: Alzheimer’s disease is one of the most prevailing age-dependent neurodegenerative diseases and the most common cause of dementia. The pharmacological therapies available for the disease provide only symptomatic relief. Plants are being extensively investigated for Alzheimer’s as they are relatively safer and cheaper. This review summarizes recent findings suggesting anti- Alzheimer potential of the plants along with compounds or mechanisms responsible for their efficacy and their therapeutic targets. The findings of recent studies have revealed that the plants or the compounds isolated from them exhibit mitigative potential in Alzheimer’s disease by targeting amyloid beta, tau protein, cholinergic pathways via various enzymes like beta secretase, gamma secretase, acetylcholinesterase or receptors involved in these pathways. A number of putative compounds revealed from these studies can be investigated further for the mitigation of Alzheimer’s disease.
Export Options
About this article
Cite this article as:
Kaushik Chetna and Yadav Prarthna *, Potential Phytotherapeutic Approaches for the Treatment of Alzheimer’s Disease: An Overview, Current Traditional Medicine 2021; 7 (3) . https://dx.doi.org/10.2174/2215083806999201125121632
DOI https://dx.doi.org/10.2174/2215083806999201125121632 |
Print ISSN 2215-0838 |
Publisher Name Bentham Science Publisher |
Online ISSN 2215-0846 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Contribution of DTI in Determining the Relationship of Epilepsy and Brain Lesions in Children with Tuberous Sclerosis
Current Medical Imaging Transglutaminase Activity as a Possible Therapeutical Target in Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review
Recent Patents on Drug Delivery & Formulation Physiology, Pharmacology and Pathophysiology of the pH Regulatory Transport Proteins NHE1 and NBCn1: Similarities, Differences, and Implications for Cancer Therapy
Current Pharmaceutical Design In-vitro Functionality of Clozapine Biphasic Release Minitablet Using Advanced Statistical Tools
Drug Delivery Letters Status of Selinum spp. L. a Himalayan Medicinal Plant in India: A Review of Its Pharmacology, Phytochemistry and Traditional Uses
Current Pharmaceutical Biotechnology Vital Elements of the Wnt-Frizzled Signaling Pathway in the Nervous System
Current Neurovascular Research Focus on MicroRNAs as Biomarker in Pediatric Diseases
Current Pharmaceutical Design Structure-Activity Studies on Alpha-Conotoxins
Current Pharmaceutical Design Editorial: Perioperative Pharmacological Management: From Prescription Medications to Dietary Supplements
Current Clinical Pharmacology Meldrum's Acid in Organic Synthesis, an Outlook to Reaction Media
Current Organic Chemistry An Update on GABAρ Receptors
Current Neuropharmacology Herbal Medicines for Diabetes Management and its Secondary Complications
Current Diabetes Reviews The Double Roles of the Prostaglandin E<sub>2</sub> EP2 Receptor in Intracerebral Hemorrhage
Current Drug Targets Efficacy, Duration and Timing of Withdrawal of Prophylactic Treatment with Antiepileptic Drugs in Neurosurgical Conditions
Current Pharmaceutical Design Patent Selections
Recent Patents on DNA & Gene Sequences The Hypothalamus and Obesity
Recent Patents on CNS Drug Discovery (Discontinued) Nonsynaptic Receptors for GABA and Glutamate
Current Topics in Medicinal Chemistry Potassium Channels: Novel Emerging Biomarkers and Targets for Therapy in Cancer
Recent Patents on Anti-Cancer Drug Discovery Cold-induced Anaphylaxis: The Case of a 9-year-old Child and Review of the Literature
Endocrine, Metabolic & Immune Disorders - Drug Targets